Stéphane Boissel

Director/Board Member at ADOCIA

57 year

Health Technology

Consumer Services

Commercial Services

Profile

Stéphane Boissel currently works at SparingVision SAS, as President, Chief Executive Officer & Director from 2023, Cottages Participations SAS, as Chairman, Adocia SA, as Independent Director from 2021, Transgene, Inc., as Director, Platine Pharma Services SAS, as Director, Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd., as Director, EG 427 SAS, as Director from 2021, and The French Society of Financial Analysts, as Member.
Mr. Boissel also formerly worked at Sangamo Therapeutics France SAS, as Chief Executive Officer, Genclis SA, as Chief Executive Officer from 2014 to 2015, ElsaLys Biotech SAS, as Non-Executive Chairman from 2013 to 2018, ERYTech Pharma SA, as Director from 2004 to 2009, Pharmaxon SAS, as Director, Sangamo Therapeutics, Inc., as Executive Vice President-Corporate Strategy from 2019 to 2020, Eurazeo SE, as Vice President from 1995 to 1998, Transgene SA, as Chief Financial Officer & Executive Vice President from 2010 to 2014, Innate Pharma SA, as Chief Financial Officer & Executive Vice President in 2010, Lazard Group LLC, as Vice President in 2002, France Biotech Association, as Member, PricewaterhouseCoopers France SARL, as Auditor in 1994, and Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd., as Member-Supervisory Board.
Mr. Boissel received his graduate degree in 1993 from Université Paris Dauphine-PSL, undergraduate degree from the University of Lyon, and Masters Business Admin degree from The University of Chicago Booth School of Business.

Stéphane Boissel active positions

Companies	Position	Start
ADOCIA	Director/Board Member	21/05/2021
SparingVision SAS SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa	Chief Executive Officer	21/10/2020
Cottages Participations SAS Cottages Participations SAS MiscellaneousMiscellaneous Operates as a non-classified establishment	Chairman	-
The French Society of Financial Analysts The French Society of Financial Analysts Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	-
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.	Director/Board Member	-
Transgene, Inc. Transgene, Inc. Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors.	Director/Board Member	-
Platine Pharma Services SAS Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services	Director/Board Member	-
Genelpis SAS Genelpis SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops pinpoint DNA medicines for chronic diseases	Director/Board Member	01/03/2021

All active positions of Stéphane Boissel

Former positions of Stéphane Boissel

Companies	Position	End
SANGAMO THERAPEUTICS, INC.	Director of Finance/CFO	31/10/2019
░░░░░░░ ░░░░░░░	░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░	░░░░░░░░ ░░ ░░░░░░░░░░░	░░░░░░░░░░
░░░░░░░ ░░░░░░ ░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░

See the detail of Stéphane Boissel's experience

Training of Stéphane Boissel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Stéphane Boissel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	24
Sangamo Therapeutics, Inc. Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company	Health Technology
Eurazeo SE Eurazeo SE Investment ManagersFinance Functions as an private equity company	Finance
Transgene SA Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer	Health Technology
Innate Pharma SA Innate Pharma SA Pharmaceuticals: MajorHealth Technology Develops therapeutic antibodies that harness the immune system to improve cancer treatment and clinical outcomes	Health Technology
Lazard Group LLC Lazard Group LLC Investment ManagersFinance Provides financial advisory, asset management and investment services	Finance
Université Paris Dauphine-PSL Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
ERYTech Pharma SA ERYTech Pharma SA Pharmaceuticals: MajorHealth Technology Develops medicinal products for orphan oncology and rare diseases	Health Technology
France Biotech Association France Biotech Association Miscellaneous Commercial ServicesCommercial Services Operates an organisation for growth of health industry	Commercial Services
University of Lyon University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Sangamo Therapeutics France SAS Sangamo Therapeutics France SAS BiotechnologyHealth Technology Develops cellular immunotherapy platforms that treats severe inflammatory and autoimmune diseases	Health Technology
Pharmaxon SAS Pharmaxon SAS Pharmaceuticals: MajorHealth Technology Discovers, develops and markets therapeutic drugs controlling cell mobility	Health Technology
Genclis SA Genclis SA Miscellaneous Commercial ServicesCommercial Services Operates as a holding company with interest in providing research services to the medical and biotechnology firms	Commercial Services
Adocia SA Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases	Health Technology
The French Society of Financial Analysts The French Society of Financial Analysts Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
PricewaterhouseCoopers France SARL PricewaterhouseCoopers France SARL Miscellaneous Commercial ServicesCommercial Services Provides auditing, legal, tax and consulting services	Commercial Services
Transgene, Inc. Transgene, Inc. Founded in 1982, Transgene, Inc. is a clinical-stage biotechnology company specializing in cancer immunotherapy through viral vector engineering. The company is based in Dover, DE. The company develops individualized therapeutic vaccines using its proprietary myvac® platform, which designs personalized vaccines targeting tumor-specific neoantigens to stimulate the patient’s immune system against early-stage solid tumors. Its lead product, TG4050, is an individualized neoantigen vaccine in randomized phase 1/2 trials as an adjuvant treatment for HPV-negative head and neck squamous cell carcinoma. Transgene’s pipeline also includes oncolytic virus candidates BT-001 and TG6050, engineered to express immune-modulating antibodies and cytokines, evaluated in early-phase clinical trials for various solid tumors.
The University of Chicago Booth School of Business The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Platine Pharma Services SAS Platine Pharma Services SAS Medical/Nursing ServicesHealth Services Provides immune-monitoring services	Health Services
Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Transgene Tasly (Tianjin) Biopharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Researches, develops and manufactures immunotherapies for the treatment of oncology and infectious diseases	Commercial Services
ElsaLys Biotech SAS ElsaLys Biotech SAS Pharmaceuticals: MajorHealth Technology Designs, develops and supplies antibodies to modulate the immune system of patients	Health Technology
Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd.
SparingVision SAS SparingVision SAS BiotechnologyHealth Technology Develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa	Health Technology
Cottages Participations SAS Cottages Participations SAS MiscellaneousMiscellaneous Operates as a non-classified establishment	Miscellaneous
Genelpis SAS Genelpis SAS BiotechnologyHealth Technology Operates as a biotechnology company that develops pinpoint DNA medicines for chronic diseases	Health Technology